KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an extra shingles shot protect kidney transplant patients?
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at how well the shingles vaccine (Shingrix) works and how safe it is in adults with kidney failure who are waiting for a kidney transplant. Some participants will get an extra dose of the vaccine after their transplant to see if it improves their immune protectio…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
Pig kidney trial offers new hope for kidney failure patients
Disease control Recruiting nowThis study tests a genetically modified pig kidney (called the 10 GE Xenokidney) in 50 adults with end-stage kidney disease who cannot get a human kidney transplant or face a long wait. The goal is to see if the pig kidney works safely and well, helping people live longer and imp…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Could a single infusion of 'Peacekeeper' cells let kidney patients ditch most Anti-Rejection pills?
Disease control Recruiting nowThis study tests a new treatment called TRK-001, made from a patient's own regulatory T cells (immune 'peacekeepers'), to prevent kidney transplant rejection. About 34 adults receiving a living donor kidney will either get standard anti-rejection drugs alone or those drugs plus a…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: Singulera Therapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for kidney transplant patients: drug trial targets rejection
Disease control Recruiting nowThis study tests a new drug called ALXN2030 in 45 adults who have had a kidney transplant and are experiencing antibody-mediated rejection (AMR), where the body attacks the new kidney. The goal is to see if the drug can help resolve the rejection better than a placebo over 52 wee…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Could a common acid reflux drug protect new kidneys?
Disease control Recruiting nowThis study tests whether a medicine called vonoprazan fumarate, usually used for stomach acid, can help prevent delayed kidney function after a deceased-donor kidney transplant. About 47 first-time kidney transplant recipients will take the drug daily for a week after surgery. Th…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Pig kidney transplants begin in humans: a lifeline for those who Can't get a human donor?
Disease control Recruiting nowThis study tests whether a specially modified pig kidney (called a thymokidney) can safely work in people with end-stage kidney disease who cannot get a human kidney transplant. About 50 participants will receive the pig kidney and be followed for life to check survival, kidney f…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Could less medication be better for older kidney transplant patients?
Disease control Recruiting nowThis study looks at whether older kidney transplant patients (55+) can safely stop taking one of their anti-rejection drugs (mycophenolate mofetil) while keeping their new kidney healthy. About 350 participants will be randomly assigned to either stop the drug or continue standar…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Home workouts could boost fitness for kidney transplant hopefuls
Knowledge-focused Recruiting nowThis study looks at whether a home-based exercise program is safe and practical for adults aged 60 and older who are waiting for a kidney transplant. Participants will wear an activity tracker and may be assigned to online exercise classes or usual care. The goal is to see if the…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 00:50 UTC
-
Can a 6-Week online course help people with chronic illnesses feel more in control?
Knowledge-focused Recruiting nowThis study tests a 6-week online group program that teaches practical skills to manage chronic conditions like cancer or after a kidney transplant. Participants learn how to handle symptoms, set health goals, and communicate better with doctors. The goal is to see if the program …
Matched conditions: KIDNEY TRANSPLANTATION
Phase: NA • Sponsor: University of Haifa • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC
-
Light therapy may tame rejection in kidney transplants
Knowledge-focused Recruiting nowThis study tests whether a treatment called extracorporeal phototherapy (ECP) can help control chronic antibody-mediated rejection, a major cause of kidney transplant failure. ECP involves taking a patient's blood cells, exposing them to UV light, and returning them to the body t…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC